| Dr Howard S Lefsky, MD | |
|
805 Statesman Way, Lexington, KY 40505-4078 | |
| (502) 339-8000 | |
| Not Available |
| Full Name | Dr Howard S Lefsky |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 805 Statesman Way, Lexington, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063469039 | NPI | - | NPPES |
| 64349830 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 34938 (Kentucky) | Primary |
| Entity Name | Casey County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407829567 PECOS PAC ID: 0749193423 Enrollment ID: O20031110000044 |
News Archive
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
Kaiser Health News staff writer Mary Agnes Carey reports: "In the aftermath of Republicans' election victories, defenders of the health care law are huddling - once again - in an effort to thwart GOP efforts to eviscerate the sweeping measure" (Carey, 11/11).
A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 8 days ago
| Entity Name | Cumberland County Hospital Association Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073567608 PECOS PAC ID: 9830006618 Enrollment ID: O20040227000134 |
News Archive
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
Kaiser Health News staff writer Mary Agnes Carey reports: "In the aftermath of Republicans' election victories, defenders of the health care law are huddling - once again - in an effort to thwart GOP efforts to eviscerate the sweeping measure" (Carey, 11/11).
A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 8 days ago
| Entity Name | Monroe Medical Foundation, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134330848 PECOS PAC ID: 5092702472 Enrollment ID: O20040428000177 |
News Archive
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
Kaiser Health News staff writer Mary Agnes Carey reports: "In the aftermath of Republicans' election victories, defenders of the health care law are huddling - once again - in an effort to thwart GOP efforts to eviscerate the sweeping measure" (Carey, 11/11).
A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 8 days ago
| Entity Name | Jane Todd Crawford Memorial Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144296658 PECOS PAC ID: 5092810994 Enrollment ID: O20080613000060 |
News Archive
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
Kaiser Health News staff writer Mary Agnes Carey reports: "In the aftermath of Republicans' election victories, defenders of the health care law are huddling - once again - in an effort to thwart GOP efforts to eviscerate the sweeping measure" (Carey, 11/11).
A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Howard S Lefsky, MD 805 Statesman Way, Lexington, KY 40505-4078 Ph: (502) 339-8000 | Dr Howard S Lefsky, MD 805 Statesman Way, Lexington, KY 40505-4078 Ph: (502) 339-8000 |
News Archive
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
Kaiser Health News staff writer Mary Agnes Carey reports: "In the aftermath of Republicans' election victories, defenders of the health care law are huddling - once again - in an effort to thwart GOP efforts to eviscerate the sweeping measure" (Carey, 11/11).
A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.
› Verified 8 days ago
Mikalah Andree Ward, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Rose St Rm M-53, Lexington, KY 40536 Phone: 859-323-5083 | |
Allison Woodall, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky And Affiliates, 800 Rose St., Lexington, KY 40536 Phone: 859-323-5871 | |
Traci Westerfield, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2416 Regency Road, Lexington, KY 40503 Phone: 859-278-1316 Fax: 859-276-1574 | |
Dr. Hollis R Hilty, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1740 Nicholasville Road, Lexington, KY 40503 Phone: 859-260-6180 Fax: 859-260-6693 | |
James Byron Moore Ii, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3205 Summit Square Pl Ste 100, Lexington, KY 40509 Phone: 859-335-9041 Fax: 859-335-9072 | |
Dr. Matthew Stewart Dawson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 230 W Main St, Lexington, KY 40507 Phone: 859-309-4839 | |
Dr. Jeremiah Phelps, MD PHD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky, 800 Rose St, Lexington, KY 40536 Phone: 859-323-6762 |